Borellini Flavia — SEC Form 4 filings

SEC reporting owner CIK 1867426. 6 Form 4 filings on record with FilingPulse; latest filed 2026-07-13.

Transaction summary — filings shown

Covers all 6 filings on record, filed 2024-06-24 to 2026-07-13. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Revolution Medicines, Inc. (RVMD)Director48
PLIANT THERAPEUTICS, INC. (PLRX)Director11
Viracta Therapeutics, Inc. (VIRX)Director11

Form 4 filings — Borellini Flavia

FiledFormIssuerReported transactionsSource
2026-07-134PLIANT THERAPEUTICS, INC. (PLRX)Grant/award (A): 60,000 (derivative) @ $0EDGAR
2026-06-234Revolution Medicines, Inc. (RVMD)Grant/award (A): 1,191 @ $0 · Grant/award (A): 3,127 (derivative) @ $0EDGAR
2025-06-304Revolution Medicines, Inc. (RVMD)Grant/award (A): 3,142 @ $0 · Grant/award (A): 11,574 (derivative) @ $0EDGAR
2024-06-284/ARevolution Medicines, Inc. (RVMD)Grant/award (A): 4,248 @ $0 · Grant/award (A): 15,955 (derivative) @ $0EDGAR
2024-06-244Viracta Therapeutics, Inc. (VIRX)Grant/award (A): 50,000 (derivative) @ $0EDGAR
2024-06-244Revolution Medicines, Inc. (RVMD)Grant/award (A): 4,800 @ $0 · Grant/award (A): 16,700 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1867426 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →